789 related articles for article (PubMed ID: 26138499)
1. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.
Heimer G; Marek-Yagel D; Eyal E; Barel O; Oz Levi D; Hoffmann C; Ruzzo EK; Ganelin-Cohen E; Lancet D; Pras E; Rechavi G; Nissenkorn A; Anikster Y; Goldstein DB; Ben Zeev B
Clin Genet; 2015 Oct; 88(4):327-35. PubMed ID: 26138499
[TBL] [Abstract][Full Text] [Related]
2. A homozygous mutation in SLC1A4 in siblings with severe intellectual disability and microcephaly.
Srour M; Hamdan FF; Gan-Or Z; Labuda D; Nassif C; Oskoui M; Gana-Weisz M; Orr-Urtreger A; Rouleau GA; Michaud JL
Clin Genet; 2015 Jul; 88(1):e1-4. PubMed ID: 25930971
[TBL] [Abstract][Full Text] [Related]
3. Mutations in SLC1A4, encoding the brain serine transporter, are associated with developmental delay, microcephaly and hypomyelination.
Damseh N; Simonin A; Jalas C; Picoraro JA; Shaag A; Cho MT; Yaacov B; Neidich J; Al-Ashhab M; Juusola J; Bale S; Telegrafi A; Retterer K; Pappas JG; Moran E; Cappell J; Anyane Yeboa K; Abu-Libdeh B; Hediger MA; Chung WK; Elpeleg O; Edvardson S
J Med Genet; 2015 Aug; 52(8):541-7. PubMed ID: 26041762
[TBL] [Abstract][Full Text] [Related]
4. A novel SLC1A4 homozygous mutation causing congenital microcephaly, epileptic encephalopathy and spastic tetraparesis: a video-EEG and tractography - case study.
Pironti E; Salpietro V; Cucinotta F; Granata F; Mormina E; Efthymiou S; Scuderi C; Gagliano A; Houlden H; Di Rosa G
J Neurogenet; 2018 Dec; 32(4):316-321. PubMed ID: 29989513
[TBL] [Abstract][Full Text] [Related]
5. A Novel SLC1A4 Mutation (p.Y191*) Causes Spastic Tetraplegia, Thin Corpus Callosum, and Progressive Microcephaly (SPATCCM) With Seizure Disorder.
Abdelrahman HA; Al-Shamsi A; John A; Ali BR; Al-Gazali L
Child Neurol Open; 2019; 6():2329048X19880647. PubMed ID: 31763347
[TBL] [Abstract][Full Text] [Related]
6. A rare cause of microcephaly, thin corpus callosum and refractory epilepsy due to a novel SLC1A4 gene mutation.
Sarigecili E; Bulut FD; Anlas O
Clin Neurol Neurosurg; 2022 Jul; 218():107283. PubMed ID: 35605507
[TBL] [Abstract][Full Text] [Related]
7. Novel compound heterozygous variants (c.971delA/c.542C > T) in
Mohamed FE; Ghattas MA; Almansoori TM; Tabouni M; Baydoun I; Kizhakkedath P; John A; Alblooshi H; Shaukat Q; Al-Jasmi F
Front Pediatr; 2023; 11():1183574. PubMed ID: 37502193
[TBL] [Abstract][Full Text] [Related]
8. Novel de novo SPOCK1 mutation in a proband with developmental delay, microcephaly and agenesis of corpus callosum.
Dhamija R; Graham JM; Smaoui N; Thorland E; Kirmani S
Eur J Med Genet; 2014 Mar; 57(4):181-4. PubMed ID: 24583203
[TBL] [Abstract][Full Text] [Related]
9. Severe neurodevelopmental disorder with intractable seizures due to a novel SLC1A4 homozygous variant.
Sedláčková L; Laššuthová P; Štěrbová K; Vlčková M; Kudr M; Buksakowska I; Staněk D; Seeman P
Eur J Med Genet; 2021 Sep; 64(9):104263. PubMed ID: 34174466
[TBL] [Abstract][Full Text] [Related]
10. Microcephaly thin corpus callosum intellectual disability syndrome caused by mutated TAF2.
Hellman-Aharony S; Smirin-Yosef P; Halevy A; Pasmanik-Chor M; Yeheskel A; Har-Zahav A; Maya I; Straussberg R; Dahary D; Haviv A; Shohat M; Basel-Vanagaite L
Pediatr Neurol; 2013 Dec; 49(6):411-416.e1. PubMed ID: 24084144
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative variant in SLC1A4 causes an autosomal dominant epilepsy syndrome.
Pujol-Giménez J; Mirzaa G; Blue EE; Albano G; Miller DE; Allworth A; Bennett JT; Byers PH; Chanprasert S; Chen J; Doherty D; Folta AB; Gillentine MA; Glass I; Hing A; Horike-Pyne M; Leppig KA; Parhin A; Ranchalis J; Raskind WH; Rosenthal EA; Schwarze U; Sheppeard S; Strohbehn S; Sybert VP; Timms A; Wener M; ; Bamshad MJ; Hisama FM; Jarvik GP; Dipple KM; Hediger MA; Stergachis AB
Ann Clin Transl Neurol; 2023 Jun; 10(6):1046-1053. PubMed ID: 37194416
[TBL] [Abstract][Full Text] [Related]
12. Generation and characterization of a knock-in mouse model for spastic tetraplegia, thin corpus callosum, and progressive microcephaly (SPATCCM).
Ratz-Mitchem ML; Leary G; Grindeland A; Silvius D; Guter J; Kavanaugh MP; Gunn TM
Mamm Genome; 2023 Dec; 34(4):572-585. PubMed ID: 37642681
[TBL] [Abstract][Full Text] [Related]
13. Loss-of-function mutation in RUSC2 causes intellectual disability and secondary microcephaly.
Alwadei AH; Benini R; Mahmoud A; Alasmari A; Kamsteeg EJ; Alfadhel M
Dev Med Child Neurol; 2016 Dec; 58(12):1317-1322. PubMed ID: 27612186
[TBL] [Abstract][Full Text] [Related]
14. Truncating mutation in intracellular phospholipase A₁ gene (DDHD2) in hereditary spastic paraplegia with intellectual disability (SPG54).
Alrayes N; Mohamoud HS; Jelani M; Ahmad S; Vadgama N; Bakur K; Simpson M; Al-Aama JY; Nasir J
BMC Res Notes; 2015 Jun; 8():271. PubMed ID: 26113134
[TBL] [Abstract][Full Text] [Related]
15. Novel European SLC1A4 variant: infantile spasms and population ancestry analysis.
Conroy J; Allen NM; Gorman K; O'Halloran E; Shahwan A; Lynch B; Lynch SA; Ennis S; King MD
J Hum Genet; 2016 Aug; 61(8):761-4. PubMed ID: 27193218
[TBL] [Abstract][Full Text] [Related]
16. Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients.
Edvardson S; Gerhard F; Jalas C; Lachmann J; Golan D; Saada A; Shaag A; Ungermann C; Elpeleg O
J Med Genet; 2015 Nov; 52(11):749-53. PubMed ID: 26307567
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel homozygous TRAPPC9 gene mutation causing non-syndromic intellectual disability, speech disorder, and secondary microcephaly.
Abbasi AA; Blaesius K; Hu H; Latif Z; Picker-Minh S; Khan MN; Farooq S; Khan MA; Kaindl AM
Am J Med Genet B Neuropsychiatr Genet; 2017 Dec; 174(8):839-845. PubMed ID: 29031008
[TBL] [Abstract][Full Text] [Related]
18. Bi-allelic Variants in DYNC1I2 Cause Syndromic Microcephaly with Intellectual Disability, Cerebral Malformations, and Dysmorphic Facial Features.
Ansar M; Ullah F; Paracha SA; Adams DJ; Lai A; Pais L; Iwaszkiewicz J; Millan F; Sarwar MT; Agha Z; Shah SF; Qaisar AA; Falconnet E; Zoete V; Ranza E; Makrythanasis P; Santoni FA; Ahmed J; Katsanis N; Walsh C; Davis EE; Antonarakis SE
Am J Hum Genet; 2019 Jun; 104(6):1073-1087. PubMed ID: 31079899
[TBL] [Abstract][Full Text] [Related]
19. Further evidence that de novo missense and truncating variants in ZBTB18 cause intellectual disability with variable features.
Cohen JS; Srivastava S; Farwell Hagman KD; Shinde DN; Huether R; Darcy D; Wallerstein R; Houge G; Berland S; Monaghan KG; Poretti A; Wilson AL; Chung WK; Fatemi A
Clin Genet; 2017 May; 91(5):697-707. PubMed ID: 27598823
[TBL] [Abstract][Full Text] [Related]
20. Severe growth deficiency, microcephaly, intellectual disability, and characteristic facial features are due to a homozygous QARS mutation.
Leshinsky-Silver E; Ling J; Wu J; Vinkler C; Yosovich K; Bahar S; Yanoov-Sharav M; Lerman-Sagie T; Lev D
Neurogenetics; 2017 Jul; 18(3):141-146. PubMed ID: 28620870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
